Xbrane Biopharma
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här Invitation to presentation of Xbrane Biopharma’s interim report January – September 2024 on October 24, 2024
Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Thursday, October 24th, 2024, at 13.00 a.m. CET. Xbrane will publish the company’s interim report January – September 2024, on Thursday, October 24, 2024, at 8.00 a.m. CET.
Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – September 2024, followed by a Q&A session. The presentation will be in English. To attend, please follow the link below:
If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.
Xbrane Biopharma Q3 Report 2024 (financialhearings.com)
If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
| Datum | 2024-10-21, kl 08:00 |
| Källa | MFN |